Pericytes Protect GBM Cells from TMZ
Corresponding Organization :
Other organizations : Army Medical University, Southwest Hospital, Nanjing Medical University, Xinqiao Hospital, Daping Hospital
Variable analysis
- Treatment with TMZ (500 μmol/L)
- Pretreatment with pericyte conditioned medium (CM)
- Pretreatment with recombinant human CCL5 (10 ng/mL)
- Pretreatment with MVC (500 nmol/L)
- Apoptotic analysis using Annexin-V Apoptosis Detection Kit
- Cell survival analysis using CCK-8
- Pericytes (5 × 10^4) cultured in the upper chamber
- GBM cells (5 × 10^4) cultured in the lower chamber
- 6-well transwell apparatus
- Negative control: GBM cells without any pretreatment, followed by TMZ treatment
- Positive control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!